Phenotypic Differences between Peripheral Myelin Protein-22 (PMP22) and Myelin Protein Zero (P0) Mutations Associated with Charcot-Marie-Tooth-Related Diseases
Open Access
- 1 July 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology and Experimental Neurology
- Vol. 62 (7), 751-764
- https://doi.org/10.1093/jnen/62.7.751
Abstract
Mutations in the genes for peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) cause human hereditary neuropathies with varying clinical and pathological phenotypes. In this study, we examine the effects of representative disease-causing mutations on the subcellular distribution of their corresponding PMP22- and P0-enhanced green fluorescent protein (EGFP) fusion proteins. In transiently transfected HeLa and 293 cells, we find that wild-type P0-EGFP and PMP22-EGFP are efficiently synthesized and transported through the secretory pathway to the plasma membrane. The P0-EGFP and PMP22-EGFP mutants can be classified into several groups: those that are transported to the plasma membrane as in the majority of P0 mutants; those that are retained in the endoplasmic reticulum as in the majority of PMP22 mutants; and those that are a mixture of the two. In addition, several of these disease-causing mutations are associated with the development of abnormal intracellular cytoplasmic structures that we have previously identified as either intracellular myelin figures or aggresomes. Our studies indicate that different types of PMP22 and P0 mutations are associated with specific intracellular chaperone proteins, including calnexin and BiP, and that these associations can be altered by glycosylation. These findings indicate that the various P0 and PMP22 mutants may exert their pathogenic effects in different subcellular compartments and by different mechanisms in the mammalian cell.Keywords
This publication has 35 references indexed in Scilit:
- Mutations in the cytoplasmic domain of P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelinationThe Journal of cell biology, 2001
- Aberrant Protein Trafficking inTremblerSuggests a Disease Mechanism for Hereditary Human Peripheral NeuropathiesMolecular and Cellular Neuroscience, 1997
- Clinical Phenotypes of Different MPZ (P0) Mutations May Include Charcot–Marie–Tooth Type 1B, Dejerine–Sottas, and Congenital HypomyelinationNeuron, 1996
- Protein zero (P0)–deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathiesNature Genetics, 1995
- Protein zero, a nervous system adhesion molecule, triggers epithelial reversion in host carcinoma cells.The Journal of cell biology, 1995
- Peripheral myelin protein 22: Facts and hypothesesJournal of Neuroscience Research, 1995
- Predicting α-helix and β-strand segments of globular proteinsBioinformatics, 1994
- The cytoplasmic domain of the myelin P0 protein influences the adhesive interactions of its extracellular domain.The Journal of cell biology, 1994
- Protein zero of peripheral nerve myelin: Biosynthesis, membrane insertion, and evidence for homotypic interactionNeuron, 1990
- Compact myelin exists in the absence of basic protein in the shiverer mutant mouseNature, 1980